Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

IPC 2023 Think Tank Meeting Report Published in JID Innovations

Key highlights from the 2023 International Psoriasis Council (IPC) Think Tank Meeting have been published in JID Innovations, summarizing presentations from the Gunnar Lomholt Symposium in the Faroe Islands. Covering a diverse range of topics related to psoriasis research and treatment strategies, the report underscores the evolving understanding of the genetic basis, comorbidities, pathogenesis, and treatment strategies of psoriasis.

Presentations from the IPC Think Tank meeting offered a comprehensive exploration of historical, current, and future perspectives on psoriasis management, providing valuable insights into its evolutionary trajectory. The future holds promise for a more nuanced understanding as genetic insights, immunological memory, and real-world evidence converge to shape individualized and effective management strategies. In conclusion, the landscape of psoriasis management has shifted from historical genetic explorations to a modern era of data analytics and targeted therapeutics. Navigating this transition involves embracing historical lessons, leveraging current technologies, and advancing toward personalized treatment approaches. As we move forward, the ongoing advancements in psoriasis research and treatment offer hope for alleviating the burden of this chronic condition and improving the quality of life for affected individuals, signifying a significant paradigm shift in psoriasis patient care.

Reference

Proceedings of the Gunnar Lomholt Symposium during the IPC 2023 Think Tank at Faroe Islands, Friday, September 8, 2023. Xing Lai FY, Bachelez H, Gudjonsson J, et al. JID Innovations (2024). doi: https://doi.org/10.1016/j.xjidi.2024.100267.

Comments are closed.

Categories

Recent Posts

Psoriasis and Metabolic Health: What IPC’s Latest Publication Means for Clinical Practice

Challenging Patient Interactions: What’s Really Behind the ‘Difficult’ Label — A Conversation with Dr. John Koo

IPC Welcomes New Councilors Dr. Steven Fakharzadeh and Dr. Rodrigo Garcia Salinas

Also Read

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.

What's New

Global and Collaborative Research in Psoriasis: IPC Fellows Research Class #1 Recordings

Recordings from the IPC Fellows Research Class #1: Global and Collaborative Research in Psoriasis are now available. Program Chairs Peter van de Kerkhof, MD, PhD, and María Julia Cura, MD, led a faculty of international experts through sessions on unresolved questions in the era of effective psoriasis therapies, building global research collaborations, and connecting psoriasis research across disciplines. Watch to hear from Wolf Henning Boehncke, MD, MA, Christopher Griffiths, OBE, MD, FMedSci, and Georg Stingl, MD, as they share perspectives shaping the next generation of psoriasis research.

WATCH NOW

Wednesday, July 15, 2026

New in the IPC Resource Library: Research Skills

The IPC Resource Library now includes a dedicated Research Skills category, bringing together videos, articles, and presentations focused on building stronger research capabilities in psoriasis. Browse the current collection to find resources on topics from collaborative research methods to career development for researchers at every stage.

WATCH NOW

Thursday, July 13, 2026

New Take Tens on Psoriatic Arthritis

IPC Councilor Anna Lopez Ferrer, MD, PhD, reviews PURE-4, a four-item tool that helps dermatologists screen psoriasis patients for psoriatic arthritis (PsA) risk. She traces its evolution across three studies (2018–2026) into a validated predictor of early PsA.

IPC Councilor André Lucas Ribeiro, MD, reframes PsA as a slow transition from psoriasis, not a sudden event, opening the door to disease interception. He outlines the steps needed to get there, from harmonizing definitions to reducing inflammatory burden.

WATCH NOW

Wednesday, July 8, 2026